Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
暂无分享,去创建一个
S. Black | J. Schneider | D. Bennett | R. Petersen | C. Iadecola | O. Lopez | P. Nilsson | H. Chui | P. Gorelick | R. Higashida | S. Greenberg | C. Tzourio | D. Nyenhuis | L. Launer | D. Arnett | S. Seshadri | A. Scuteri | S. Laurent | C. DeCarli | F. Sellke | R. Lindquist | G. Román | S. Black | J. Schneider
[1] D. Craig,et al. Rivastigmine for vascular cognitive impairment. , 2013, The Cochrane database of systematic reviews.
[2] Amos D. Korczyn,et al. Vascular dementia , 1993, Journal of the Neurological Sciences.
[3] Denis A. Evans,et al. Adherence to a Mediterranean-type dietary pattern and cognitive decline in a community population. , 2011, The American journal of clinical nutrition.
[4] S. Leurgans,et al. Cerebral amyloid angiopathy pathology and cognitive domains in older persons , 2011, Annals of neurology.
[5] F. Sofi,et al. Physical activity and risk of cognitive decline: a meta‐analysis of prospective studies , 2011, Journal of internal medicine.
[6] W. Elliott. Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis , 2011 .
[7] Irene Katzan,et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. , 2011, Stroke.
[8] M. Ganguli. 38. Epidemiology of Dementia , 2010 .
[9] P. Gorelick. Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials , 2010, Annals of the New York Academy of Sciences.
[10] M. Petri,et al. Depression and Cognitive Impairment in Newly Diagnosed Systemic Lupus Erythematosus , 2010, The Journal of Rheumatology.
[11] M. O’Sullivan,et al. Impact of MRI markers in subcortical vascular dementia: A multi-modal analysis in CADASIL , 2010, Neurobiology of Aging.
[12] Eric E. Smith,et al. MRI Markers of Small Vessel Disease in Lobar and Deep Hemispheric Intracerebral Hemorrhage , 2010, Stroke.
[13] Warren J Manning,et al. Cardiac Index Is Associated With Brain Aging: The Framingham Heart Study , 2010, Circulation.
[14] S. Resnick,et al. Age, Alzheimer's disease and dementia in the Baltimore Longitudinal Study of Ageing. , 2010, Brain : a journal of neurology.
[15] Eng H. Lo,et al. The Science of Stroke: Mechanisms in Search of Treatments , 2010, Neuron.
[16] C. Iadecola. The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia , 2010, Acta Neuropathologica.
[17] C. DeCarli,et al. Randomized, Placebo-Controlled, Clinical Trial of Donepezil in Vascular Dementia: Differential Effects by Hippocampal Size , 2010, Stroke.
[18] N. Schröder,et al. Reversal of age-associated memory impairment by rosuvastatin in rats , 2010, Experimental Gerontology.
[19] T. Billiar,et al. Linking oxidative stress to inflammation: Toll-like receptors. , 2010, Free radical biology & medicine.
[20] V. Gudnason,et al. Coronary Artery Calcium, Brain Function and Structure: The AGES-Reykjavik Study , 2010, Stroke.
[21] B. Horne,et al. Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia. , 2010, Heart rhythm.
[22] K. Narasimhalu,et al. A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular disease , 2010, Acta neurologica Scandinavica.
[23] Sudha Seshadri,et al. Association of MRI Markers of Vascular Brain Injury With Incident Stroke, Mild Cognitive Impairment, Dementia, and Mortality: The Framingham Offspring Study , 2010, Stroke.
[24] H. Markus,et al. Clinical Spectrum of CADASIL and the Effect of Cardiovascular Risk Factors on Phenotype: Study in 200 Consecutively Recruited Individuals , 2010, Stroke.
[25] D. Sparks,et al. Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease , 2010, Neurology.
[26] H. Vinters,et al. Cerebral Microinfarcts Associated with Severe Cerebral β‐Amyloid Angiopathy , 2010, Brain pathology.
[27] Stirling Bryan,et al. Promotion of the mind through exercise (PROMoTE): a proof-of-concept randomized controlled trial of aerobic exercise training in older adults with vascular cognitive impairment , 2010, BMC neurology.
[28] C. Rowe,et al. 11C-PIB binding is increased in patients with cerebral amyloid angiopathy–related hemorrhage , 2010, Neurology.
[29] C. Brayne,et al. Population variation in oxidative stress and astrocyte DNA damage in relation to Alzheimer‐type pathology in the ageing brain , 2010, Neuropathology and applied neurobiology.
[30] M. Fornage,et al. Genome-Wide Association Studies of MRI-Defined Brain Infarcts: Meta-Analysis From the CHARGE Consortium , 2010, Stroke.
[31] David J. Begley,et al. Structure and function of the blood–brain barrier , 2010, Neurobiology of Disease.
[32] P. Sawchenko,et al. Dual Roles for Perivascular Macrophages in Immune-to-Brain Signaling , 2010, Neuron.
[33] J. Cauley,et al. 25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men , 2010, Neurology.
[34] L. Ferrucci,et al. Nonsteroidal Anti‐Inflammatory Drugs, Aspirin, and Cognitive Function in the Baltimore Longitudinal Study of Aging , 2010, Journal of the American Geriatrics Society.
[35] Ron Brookmeyer,et al. Dementia incidence continues to increase with age in the oldest old: The 90+ study , 2010, Annals of neurology.
[36] Egill Rostrup,et al. Cerebral Blood Flow Response to Functional Activation , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[37] K. Arai,et al. Astrocytes protect oligodendrocyte precursor cells via MEK/ERK and PI3K/Akt signaling , 2009, Journal of neuroscience research.
[38] L. Fratiglioni,et al. Vascular and psychosocial factors in Alzheimer's disease: epidemiological evidence toward intervention. , 2010, Journal of Alzheimer's disease : JAD.
[39] Glen E Duncan,et al. Effects of aerobic exercise on mild cognitive impairment: a controlled trial. , 2010, Archives of neurology.
[40] Carol Brayne,et al. Age, neuropathology, and dementia. , 2009, The New England journal of medicine.
[41] A. Spiro,et al. Intakes of (n-3) fatty acids and fatty fish are not associated with cognitive performance and 6-year cognitive change in men participating in the Veterans Affairs Normative Aging Study. , 2009, The Journal of nutrition.
[42] V. Hachinski,et al. Changing perspectives regarding late-life dementia , 2009, Nature Reviews Neurology.
[43] Owen Carmichael,et al. Regional pattern of white matter microstructural changes in normal aging, MCI, and AD , 2009, Neurology.
[44] P. Sachdev,et al. The determinants and longitudinal course of post-stroke mild cognitive impairment , 2009, Journal of the International Neuropsychological Society.
[45] S. Pendlebury,et al. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis , 2009, The Lancet Neurology.
[46] I. McKeith,et al. Epidemiological Pathology of Dementia: Attributable-Risks at Death in the Medical Research Council Cognitive Function and Ageing Study , 2009, PLoS medicine.
[47] P. Passmore,et al. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. , 2009, The Cochrane database of systematic reviews.
[48] C. Victora. Nutrition in early life: a global priority , 2009, The Lancet.
[49] D. Royall,et al. Sertraline improves executive function in patients with vascular cognitive impairment. , 2009, The Journal of neuropsychiatry and clinical neurosciences.
[50] C. Tzourio,et al. A cross-sectional and longitudinal study of the relationship between walking speed and cognitive function in community-dwelling elderly people. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.
[51] T. Sobrino,et al. Plasma &bgr;-Amyloid 1-40 Is Associated With the Diffuse Small Vessel Disease Subtype , 2009, Stroke.
[52] A. Zonderman,et al. Carotid Intimal Medial Thickness Predicts Cognitive Decline Among Adults Without Clinical Vascular Disease , 2009, Stroke.
[53] J. J. Couey,et al. Nicotinic actions on neuronal networks for cognition: general principles and long-term consequences. , 2009, Biochemical pharmacology.
[54] R. Kalaria. Linking cerebrovascular defense mechanisms in brain ageing and Alzheimer's disease , 2009, Neurobiology of Aging.
[55] M. van Buchem,et al. Descriptive Analysis of the Boston Criteria Applied to a Dutch-Type Cerebral Amyloid Angiopathy Population , 2009, Stroke.
[56] M. Robbins,et al. Presence of the APOE ε4 allele modifies the relationship between type 2 diabetes and cognitive performance: the Maine–Syracuse Study , 2009, Diabetologia.
[57] M. Woodward,et al. Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial , 2009, Diabetologia.
[58] J. M. Wardlaw,et al. Blood brain barrier: ageing and microvascular disease-systematic review and meta-analysis , 2009, Journal of the Neurological Sciences.
[59] V. Šerić,et al. Vascular characteristics of patients with dementia , 2009, Journal of the Neurological Sciences.
[60] Y. Mimori,et al. Incidence and risks of dementia in Japanese women: Radiation Effects Research Foundation Adult Health Study , 2009, Journal of the Neurological Sciences.
[61] Yaakov Stern,et al. Physical activity, diet, and risk of Alzheimer disease. , 2009, JAMA.
[62] Virginie Rondeau,et al. Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. , 2009, JAMA.
[63] T. Cukierman-Yaffe. Relationship Between Baseline Glycemic Control and Cognitive Function in Individuals With Type 2 Diabetes and Other Cardiovascular Risk Factors: The Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Trial , 2009, Diabetes Care.
[64] S. Greenberg,et al. Cerebrospinal fluid amyloid β40 is decreased in cerebral amyloid angiopathy , 2009, Annals of neurology.
[65] S. Leurgans,et al. The neuropathology of probable Alzheimer disease and mild cognitive impairment , 2009, Annals of neurology.
[66] M. Folstein,et al. Vitamin D is associated with cognitive function in elders receiving home health services. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.
[67] Stéphane Laurent,et al. Large and small artery cross-talk and recent morbidity-mortality trials in hypertension. , 2009, Hypertension.
[68] S. Seliger,et al. Chronic kidney disease, creatinine and cognitive functioning. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[69] Claudia Altamura,et al. Carotid atherosclerosis and cognitive decline in patients with Alzheimer's disease , 2009, Neurobiology of Aging.
[70] M. Kivipelto,et al. Midlife Serum Cholesterol and Increased Risk of Alzheimer’s and Vascular Dementia Three Decades Later , 2009, Dementia and Geriatric Cognitive Disorders.
[71] M. Dichgans,et al. CADASIL , 2009, The Lancet Neurology.
[72] J. Kaye,et al. Cognitive impairment risk , 2009, Neurology.
[73] Randall J Bateman,et al. A γ‐secretase inhibitor decreases amyloid‐β production in the central nervous system , 2009, Annals of neurology.
[74] M. Folstein,et al. Validity of estimated dietary eicosapentaenoic acid and docosahexaenoic acid intakes determined by interviewer-administered food frequency questionnaire among older adults with mild-to-moderate cognitive impairment or dementia. , 2009, American journal of epidemiology.
[75] G. Hankey,et al. Retinal microvasculature in acute lacunar stroke: a cross-sectional study , 2009, The Lancet Neurology.
[76] Stéphane Laurent,et al. Vascular aging: A tale of EVA and ADAM in cardiovascular risk assessment and prevention. , 2009, Hypertension.
[77] S. Rubin,et al. Predictors of maintaining cognitive function in older adults , 2009, Neurology.
[78] J. Manson,et al. Vitamin E, Vitamin C, Beta Carotene, and Cognitive Function Among Women With or at Risk of Cardiovascular Disease: The Women’s Antioxidant and Cardiovascular Study , 2009, Circulation.
[79] OphéliaGodin,et al. Severe Cerebral White Matter Hyperintensities Predict Severe Cognitive Decline in Patients With Cerebrovascular Disease History , 2009 .
[80] S. MacDonald,et al. Serum total cholesterol, statins and cognition in non-demented elderly , 2009, Neurobiology of Aging.
[81] C. Sigmund,et al. Role of oxidative stress and AT1 receptors in cerebral vascular dysfunction with aging. , 2009, American journal of physiology. Heart and circulatory physiology.
[82] B. Graubard,et al. Prevention and Epidemiology , 2022 .
[83] N. Sattar,et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials , 2009, The Lancet.
[84] C. Thompson,et al. Living beyond our physiological means: small vessel disease of the brain is an expression of a systemic failure in arteriolar function: a unifying hypothesis. , 2009, Stroke.
[85] M. Fornage,et al. Genomewide association studies of stroke. , 2009, The New England journal of medicine.
[86] Ming Liu,et al. Huperzine A for vascular dementia. , 2009, The Cochrane database of systematic reviews.
[87] Kristine Yaffe,et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. , 2009, JAMA.
[88] PatrickLacolley,et al. Vascular Structure and Function Is Correlated to Cognitive Performance and White Matter Hyperintensities in Older Hypertensive Patients With Subjective Memory Complaints , 2009 .
[89] B. Lawlor,et al. Blood pressure and the risk for dementia—A double edged sword , 2009, Ageing Research Reviews.
[90] W. Abhayaratna,et al. Arterial Pulse Wave Velocity and Cognition With Advancing Age , 2009, Hypertension.
[91] W. M. van der Flier,et al. Progression of Mild Cognitive Impairment to Dementia: Contribution of Cerebrovascular Disease Compared With Medial Temporal Lobe Atrophy , 2009, Stroke.
[92] Toshiko Tanaka,et al. COL4A1 Is Associated With Arterial Stiffness by Genome-Wide Association Scan , 2009, Circulation. Cardiovascular genetics.
[93] Amy E. Sanders,et al. Leisure Activities and Risk of Vascular Cognitive Impairment in Older Adults , 2009, Journal of geriatric psychiatry and neurology.
[94] Peter K Stys,et al. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis , 2009, The Lancet Neurology.
[95] K. Yaffe,et al. The metabolic syndrome and development of cognitive impairment among older women. , 2009, Archives of neurology.
[96] Lewis H Kuller,et al. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. , 2009, Archives of neurology.
[97] Suzanne Craft,et al. The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. , 2009, Archives of neurology.
[98] C. Iadecola,et al. Threats to the Mind: Aging, Amyloid, and Hypertension , 2009, Stroke.
[99] Sandra Black,et al. Understanding White Matter Disease: Imaging-Pathological Correlations in Vascular Cognitive Impairment , 2009, Stroke.
[100] R. Weller,et al. Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapy , 2009, Acta Neuropathologica.
[101] R. Deane,et al. SRF and myocardin regulate LRP-mediated amyloid-β clearance in brain vascular cells , 2009, Nature Cell Biology.
[102] L. Kalra,et al. Cognitive function and hypertension , 2009, Journal of Human Hypertension.
[103] J. O'Brien,et al. Microarray RNA Expression Analysis of Cerebral White Matter Lesions Reveals Changes in Multiple Functional Pathways , 2009, Stroke.
[104] C. Tzourio,et al. Vascular risk factors and dementia , 2009, Neurology.
[105] D. Miao,et al. Physical activity and cognitive function in Alzheimer disease. , 2009, JAMA.
[106] H. Kuo,et al. Diabetes and the Risk of Multi-System Aging Phenotypes: A Systematic Review and Meta-Analysis , 2009, PloS one.
[107] D. Tate,et al. Vascular and cognitive functions associated with cardiovascular disease in the elderly , 2009, Journal of clinical and experimental neuropsychology.
[108] A. Scuteri,et al. Impact of Fasting Glycemia and Regional Cerebral Perfusion in Diabetic Subjects: A Study With Technetium-99m-Ethyl Cysteinate Dimer Single Photon Emission Computed Tomography , 2009, Stroke.
[109] O. J. Greve,et al. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjögren syndrome: a comparative population-based study , 2008, Annals of the rheumatic diseases.
[110] C. DeCarli,et al. Vascular cognitive impairment: Prodrome to vaD? , 2009 .
[111] W. Elliott. Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events , 2009 .
[112] J. Blass. Duration of antihypertensive drug use and risk of dementia: A prospective cohort study , 2009 .
[113] J. Blass. Mediterranean Diet and Mild Cognitive Impairment , 2009 .
[114] E. Haacke,et al. Serial susceptibility weighted MRI measures brain iron and microbleeds in dementia. , 2009, Journal of Alzheimer's disease : JAD.
[115] S. Tsuji,et al. Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. , 2009, The New England journal of medicine.
[116] S. Haneuse,et al. Neuropathology-based risk scoring for dementia diagnosis in the elderly. , 2009, Journal of Alzheimer's disease : JAD.
[117] P. Passmore,et al. Statins for the prevention of dementia. , 2009, The Cochrane database of systematic reviews.
[118] D. Bennett,et al. The neuropathology of older persons with and without dementia from community versus clinic cohorts. , 2009, Journal of Alzheimer's disease : JAD.
[119] P. Macfarlane,et al. Pravastatin and cognitive function in the elderly. Results of the PROSPER study , 2009, Journal of Neurology.
[120] David M Holtzman,et al. Cerebrovascular Dysfunction in Amyloid Precursor Protein Transgenic Mice: Contribution of Soluble and Insoluble Amyloid-β Peptide, Partial Restoration via γ-Secretase Inhibition , 2008, The Journal of Neuroscience.
[121] S. Gauthier,et al. Diagnosis and treatment of dementia: 6. Management of severe Alzheimer disease , 2008, Canadian Medical Association Journal.
[122] J. Manson,et al. A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease. , 2008, The American journal of clinical nutrition.
[123] N. Sattar,et al. Does Low to Moderate Alcohol Intake Protect Against Cognitive Decline in Older People? , 2008, Journal of the American Geriatrics Society.
[124] Peter W de Leeuw,et al. Increased Aortic Pulse Wave Velocity Is Associated With Silent Cerebral Small-Vessel Disease in Hypertensive Patients , 2008, Hypertension.
[125] V. Gudnason,et al. American Journal of Epidemiology Original Contribution Cognitive Impairment: an Increasingly Important Complication of Type 2 Diabetes the Age, Gene/environment Susceptibility–reykjavik Study , 2022 .
[126] V. Hachinski. Shifts in thinking about dementia. , 2008, JAMA.
[127] H. Chertkow,et al. Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia , 2008, Canadian Medical Association Journal.
[128] R. D'Agostino,et al. Prevalence and Correlates of Silent Cerebral Infarcts in the Framingham Offspring Study , 2008, Stroke.
[129] S. Kanba,et al. Incidence and survival of dementia in a general population of Japanese elderly: the Hisayama study , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[130] H. Chui,et al. Understanding hippocampal sclerosis in the elderly: Epidemiology, characterization, and diagnostic issues , 2008, Current neurology and neuroscience reports.
[131] J. Grimley Evans,et al. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. , 2008, The Cochrane database of systematic reviews.
[132] E. Teper,et al. Vascular factors and depression , 2008, International journal of geriatric psychiatry.
[133] S. Yusuf,et al. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo , 2008, The Lancet Neurology.
[134] F. Grodstein,et al. Plasma carotenoids and tocopherols and cognitive function: A prospective study , 2008, Neurobiology of Aging.
[135] M. Bates,et al. Social support and cognitive impairment in clients receiving treatment for alcohol- and drug-use disorders: a replication study. , 2008, Journal of studies on alcohol and drugs.
[136] Piero Antuono,et al. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors , 2008, The Lancet Neurology.
[137] I. Deary,et al. Low dose aspirin and cognitive function in middle aged to elderly adults: randomised controlled trial , 2008, BMJ : British Medical Journal.
[138] V. Hachinski. World Stroke Day 2008: "little strokes, big trouble". , 2008, Stroke.
[139] B. Furie,et al. Mechanisms of thrombus formation. , 2008, The New England journal of medicine.
[140] C. Bulpitt,et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial , 2008, The Lancet Neurology.
[141] K. Jellinger. Morphologic diagnosis of “vascular dementia” — A critical update , 2008, Journal of the Neurological Sciences.
[142] Kent L Thornburg,et al. Effect of in Utero and Early-life Conditions on Adult Health and Disease Epidemiol Ogic a Nd Clinic a L Observations , 2022 .
[143] E. Schiffrin,et al. Role of the renin-angiotensin system in vascular inflammation. , 2008, Trends in pharmacological sciences.
[144] Eric E. Smith,et al. Tissue Microstructural Changes Are Independently Associated With Cognitive Impairment in Cerebral Amyloid Angiopathy , 2008, Stroke.
[145] Kathryn Lunetta,et al. Magnetic Resonance Imaging Traits in Siblings Discordant for Alzheimer Disease , 2008, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[146] C. Marra,et al. Patterns of neuropsychological impairment in MCI patients with small subcortical infarcts or hippocampal atrophy , 2008, Journal of the International Neuropsychological Society.
[147] K. Rockwood,et al. Prevention of CIND by physical activity: Different impact on VCI-ND compared with MCI , 2008, Journal of the Neurological Sciences.
[148] P. Zandi,et al. No advantage of Aβ42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies , 2008, Neurology.
[149] M. Marmot,et al. Smoking history and cognitive function in middle age from the Whitehall II study. , 2008, Archives of internal medicine.
[150] C. Iadecola,et al. Hypertension and cerebrovascular dysfunction. , 2008, Cell metabolism.
[151] P. Nilsson,et al. The early life origins of vascular ageing and cardiovascular risk: the EVA syndrome , 2008, Journal of hypertension.
[152] Diana B Petitti,et al. Social network, cognitive function, and dementia incidence among elderly women. , 2008, American journal of public health.
[153] E. Lo,et al. Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons , 2008, Proceedings of the National Academy of Sciences.
[154] G. Ravaglia,et al. Physical activity and dementia risk in the elderly , 2008, Neurology.
[155] Geert Jan Biessels,et al. Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. , 2008, European journal of pharmacology.
[156] H. Beydoun,et al. Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta‐analysis , 2008, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[157] Istvan Csapo,et al. Spatial Distribution of White-Matter Hyperintensities in Alzheimer Disease, Cerebral Amyloid Angiopathy, and Healthy Aging , 2008, Stroke.
[158] S. Salloway,et al. Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL , 2008, The Lancet Neurology.
[159] J. Claassen,et al. Cerebral Autoregulation: An Overview of Current Concepts and Methodology with Special Focus on the Elderly , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[160] S. DeKosky,et al. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease , 2008, Brain : a journal of neurology.
[161] K. Rockwood,et al. Vascular cognitive impairment: current concepts and clinical developments , 2008, The Lancet Neurology.
[162] Ki Woong Kim,et al. Lack of Association Between Apolipoprotein E Polymorphism and Vascular Dementia in Koreans , 2008, Journal of geriatric psychiatry and neurology.
[163] P. Carmeliet,et al. Neurovascular signalling defects in neurodegeneration , 2008, Nature Reviews Neuroscience.
[164] John D E Gabrieli,et al. Gray Matter Atrophy in Patients With Ischemic Stroke With Cognitive Impairment , 2008, Stroke.
[165] R. Sacco,et al. Prevalence and determinants of subclinical brain infarction , 2008, Neurology.
[166] P. Mehta,et al. Intranasal insulin improves cognition and modulates β-amyloid in early AD , 2008, Neurology.
[167] Ping Zhou,et al. Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein , 2008, Proceedings of the National Academy of Sciences.
[168] B. Zlokovic. The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders , 2008, Neuron.
[169] P. Mecocci,et al. Mild Cognitive Impairment: Epidemiology and Dementia Risk in an Elderly Italian Population , 2008, Journal of the American Geriatrics Society.
[170] D. Tomassoni,et al. Nimodipine and Its Use in Cerebrovascular Disease: Evidence from Recent Preclinical and Controlled Clinical Studies , 2008, Clinical and experimental hypertension.
[171] Norbert Schuff,et al. Neuropathological basis of magnetic resonance images in aging and dementia , 2008, Annals of neurology.
[172] Julian F. Thayer,et al. Pulse Pressure and Pulse Wave Velocity Are Related to Cognitive Decline in the Baltimore Longitudinal Study of Aging , 2008, Hypertension.
[173] A. Verma,et al. Imaging of Amyloid Burden and Distribution in Cerebral Amyloid Angiopathy , 2008 .
[174] T. Grabowski. Course of cerebral amyloid angiopathy–related inflammation , 2008 .
[175] A. Aleman,et al. Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment. , 2008, The Cochrane database of systematic reviews.
[176] M. Reger,et al. Intranasal insulin improves cognition and modulates beta-amyloid in early AD. , 2008, Neurology.
[177] H. Wolburg,et al. Brain endothelial cells and the glio-vascular complex , 2008, Cell and Tissue Research.
[178] B. McGuinness,et al. Systematic review: blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[179] David A. Bennett,et al. Mixed brain pathologies account for most dementia cases in community-dwelling older persons , 2007, Neurology.
[180] C. Patterson,et al. Blood inflammatory markers and risk of dementia: The Conselice Study of Brain Aging , 2007, Neurobiology of Aging.
[181] Yuko Saito,et al. Neuropathology of mild cognitive impairment , 2007, Neuropathology : official journal of the Japanese Society of Neuropathology.
[182] K. Blennow,et al. Mid‐life adiposity factors relate to blood–brain barrier integrity in late life , 2007, Journal of internal medicine.
[183] C. Iadecola,et al. Nox2-Derived Reactive Oxygen Species Mediate Neurovascular Dysregulation in the Aging Mouse Brain , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[184] Sudha Seshadri,et al. Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study , 2007, The Lancet Neurology.
[185] R. Mayeux,et al. Hypertension and the risk of mild cognitive impairment. , 2007, Archives of neurology.
[186] W. M. van der Flier,et al. The Contribution of Medial Temporal Lobe Atrophy and Vascular Pathology to Cognitive Impairment in Vascular Dementia , 2007, Stroke.
[187] L. Launer,et al. Ankle-to-Brachial Index and Dementia: The Honolulu-Asia Aging Study , 2007, Circulation.
[188] C. Iadecola,et al. Glial regulation of the cerebral microvasculature , 2007, Nature Neuroscience.
[189] S. Haneuse,et al. Pathological correlates of dementia in a longitudinal, population‐based sample of aging , 2007, Annals of neurology.
[190] C. Bocti,et al. Management of dementia with a cerebrovascular component , 2007, Alzheimer's & Dementia.
[191] V. Libri,et al. PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis. , 2007, Brain : a journal of neurology.
[192] R. Klein,et al. Aortic Distensibility and Retinal Arteriolar Narrowing: The Multi-Ethnic Study of Atherosclerosis , 2007, Hypertension.
[193] R. Schmieder,et al. Increased Wall: Lumen Ratio of Retinal Arterioles in Male Patients With a History of a Cerebrovascular Event , 2007, Hypertension.
[194] M. Kivipelto,et al. Carotid Intima-Media Thickness and Cognitive Function in Elderly Women: A Population-Based Study , 2007, Neuroepidemiology.
[195] L. Schneider,et al. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials , 2007, The Lancet Neurology.
[196] S. Nelson,et al. C-terminal truncations in human 3′-5′ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy , 2007, Nature Genetics.
[197] Carl W. Cotman,et al. Exercise builds brain health: key roles of growth factor cascades and inflammation , 2007, Trends in Neurosciences.
[198] Kaarin J Anstey,et al. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. , 2007, American journal of epidemiology.
[199] J. O'Brien,et al. White matter lesions in an unselected cohort of the elderly: astrocytic, microglial and oligodendrocyte precursor cell responses , 2007, Neuropathology and applied neurobiology.
[200] S. Salloway,et al. Galantamine treatment of vascular dementia , 2007, Neurology.
[201] D. Bennett,et al. Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons , 2007, Annals of neurology.
[202] Ronald A Cohen,et al. Lower Cardiac Output Is Associated with Greater White Matter Hyperintensities in Older Adults with Cardiovascular Disease , 2007, Journal of the American Geriatrics Society.
[203] D. Heistad,et al. Cerebral Vascular Dysfunction During Hypercholesterolemia , 2007, Stroke.
[204] Kathryn Ziegler-Graham,et al. Forecasting the global burden of Alzheimer’s disease , 2007, Alzheimer's & Dementia.
[205] Dixon M. Moody,et al. Vascular dementia in leukoaraiosis may be a consequence of capillary loss not only in the lesions, but in normal-appearing white matter and cortex as well , 2007, Journal of the Neurological Sciences.
[206] Stéphane Laurent,et al. Recent advances in arterial stiffness and wave reflection in human hypertension. , 2007, Hypertension.
[207] Massimo Volpe,et al. Arterial stiffness as an independent predictor of longitudinal changes in cognitive function in the older individual , 2007, Journal of hypertension.
[208] J. Manson,et al. Low dose aspirin and cognitive function in the women's health study cognitive cohort , 2007, BMJ : British Medical Journal.
[209] J. Seward,et al. Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a community-based cohort. , 2007, European heart journal.
[210] A. Federico,et al. DIAGNOSTIC VALUE OF ULTRASTRUCTURAL SKIN BIOPSY STUDIES IN CADASIL , 2007, Neurology.
[211] W. Peng,et al. Acupuncture for vascular dementia. , 2007, The Cochrane database of systematic reviews.
[212] I. Deary,et al. Cognitive epidemiology , 2007, Journal of Epidemiology and Community Health.
[213] A. Folsom,et al. Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study. , 2007, The American journal of clinical nutrition.
[214] J. Dartigues,et al. Depressive Symptoms, Major Depressive Episode and Cognition in the Elderly: The Three-City Study , 2007, Neuroepidemiology.
[215] P. Wolf,et al. Relation of obesity to cognitive function: importance of central obesity and synergistic influence of concomitant hypertension. The Framingham Heart Study. , 2007, Current Alzheimer research.
[216] P. Hof,et al. Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia , 2007, Neurology.
[217] V. Hachinski. The 2005 Thomas Willis Lecture: Stroke and Vascular Cognitive Impairment: A Transdisciplinary, Translational and Transactional Approach , 2007, Stroke.
[218] R. Petersen,et al. Erratum: National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards (Stroke (2006) 37, 9, (2220-2241)) , 2007 .
[219] R. Paul,et al. Systemic hypoperfusion is associated with executive dysfunction in geriatric cardiac patients , 2007, Neurobiology of Aging.
[220] W. Jagust,et al. Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease. , 2007, Brain : a journal of neurology.
[221] D. Streiner,et al. Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients. , 2007, Archives of neurology.
[222] B. Yoon,et al. Retinopathy as an indicator of silent brain infarction in asymptomatic hypertensive subjects , 2007, Journal of the Neurological Sciences.
[223] J. Jeret. Prevalence and severity of microbleeds in a memory clinic setting , 2007, Neurology.
[224] Petra Verhoef,et al. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial , 2007, The Lancet.
[225] Andrew Brooks,et al. Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype , 2007, Proceedings of the National Academy of Sciences.
[226] B. Demaerschalk,et al. Treatment of Vascular Dementia and Vascular Cognitive Impairment , 2007, The neurologist.
[227] A. Waldo. Atrial Fibrillation Is Associated With Lower Cognitive Performance in the Framingham Offspring Men , 2007 .
[228] D. Grobbee,et al. Cardiovascular disease and cognitive performance in middle-aged and elderly men. , 2007, Atherosclerosis.
[229] D. Harvey,et al. Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD , 2006, Neurology.
[230] S. Carmichael,et al. A Neurovascular Niche for Neurogenesis after Stroke , 2006, The Journal of Neuroscience.
[231] Chris Zarow,et al. Cognitive impact of subcortical vascular and Alzheimer's disease pathology , 2006, Annals of neurology.
[232] Thomas G Beach,et al. Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging. , 2006, Archives of neurology.
[233] J. Manly,et al. Deconstructing Race and Ethnicity: Implications for Measurement of Health Outcomes , 2006, Medical care.
[234] H. Struijker‐Boudier,et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. , 2006, European heart journal.
[235] D. Drachman. Aging of the brain, entropy, and Alzheimer disease , 2006, Neurology.
[236] D. Evans,et al. Associations of vegetable and fruit consumption with age-related cognitive change , 2006, Neurology.
[237] L. Kalra,et al. The effects of blood pressure reduction on cognitive function: a review of effects based on pooled data from clinical trials , 2006, Journal of hypertension.
[238] A. Thrift,et al. Long-Term Cognitive Transitions, Rates of Cognitive Change, and Predictors of Incident Dementia in a Population-Based First-Ever Stroke Cohort , 2006, Stroke.
[239] J. Bourre,et al. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. , 2006, The journal of nutrition, health & aging.
[240] Martin Dichgans,et al. Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: a two-centre cohort study. , 2006, Brain : a journal of neurology.
[241] S. Black,et al. National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards , 2006, Stroke.
[242] M. Hennerici,et al. High-dose atorvastatin after stroke or transient ischemic attack. , 2006, The New England journal of medicine.
[243] T. Manolio,et al. Education and the cognitive decline associated with MRI-defined brain infarct , 2006, Neurology.
[244] J. Cashy,et al. Stable cognition after coronary artery bypass grafting: comparisons with percutaneous intervention and normal controls. , 2006, The Annals of thoracic surgery.
[245] C. Rochester,et al. EXERCISE IS ASSOCIATED WITH REDUCED RISK FOR INCIDENT DEMENTIA AMONG PERSONS 65 YEARS OF AGE AND OLDER , 2006 .
[246] Aad van der Lugt,et al. O3-04-07 Prevalence and risk factors of cerebral microbleeds in the Rotterdam scan study , 2006, Alzheimer's & Dementia.
[247] H. Chui. Vascular cognitive impairment: Today and tomorrow , 2006, Alzheimer's & Dementia.
[248] J. Mann,et al. A controlled trial of homocysteine lowering and cognitive performance. , 2006, The New England journal of medicine.
[249] V. Álvarez,et al. A new de novo Notch3 mutation causing CADASIL , 2006, European journal of neurology.
[250] J. O'Brien,et al. White Matter Lesions in an Unselected Cohort of the Elderly: Molecular Pathology Suggests Origin From Chronic Hypoperfusion Injury , 2006, Stroke.
[251] P. Zandi,et al. Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. , 2006, Archives of neurology.
[252] E. Tangalos,et al. Neuropathologic features of amnestic mild cognitive impairment. , 2006, Archives of neurology.
[253] Lenore J Launer,et al. Reducing the Risk of Dementia: Efficacy of Long-Term Treatment of Hypertension , 2006, Stroke.
[254] J. Sundberg,et al. Role of COL4A1 in small-vessel disease and hemorrhagic stroke. , 2006, The New England journal of medicine.
[255] Oscar L Lopez,et al. Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study. , 2006, Archives of general psychiatry.
[256] Albert Hofman,et al. Arterial Stiffness and Risk of Coronary Heart Disease and Stroke: The Rotterdam Study , 2006, Circulation.
[257] Oscar L Lopez,et al. Perspectives on depression, mild cognitive impairment, and cognitive decline. , 2006, Archives of general psychiatry.
[258] F. Faraci. Reactive oxygen species: influence on cerebral vascular tone. , 2006, Journal of applied physiology.
[259] Hiroko H Dodge,et al. Depressive symptoms and cognitive decline in late life: a prospective epidemiological study. , 2006, Archives of general psychiatry.
[260] D. Craig,et al. Galantamine for vascular cognitive impairment. , 2006, The Cochrane database of systematic reviews.
[261] Eric E. Smith,et al. Plasma β-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy , 2006, Neurology.
[262] W. Jackson. Physical activity, cognitive activity, and cognitive decline in a biracial community population , 2006 .
[263] M. Safar,et al. Arterial stiffness in hypertension , 2006 .
[264] J. Growdon,et al. Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. , 2006, Neurology.
[265] D. Campion,et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy , 2006, Nature Genetics.
[266] Charles D. Smith,et al. Neuropathologic substrate of mild cognitive impairment. , 2006, Archives of neurology.
[267] Jon Andresen,et al. Endothelial influences on cerebrovascular tone. , 2006, Journal of applied physiology.
[268] J. Bourre. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 2 : macronutrients. , 2006, The journal of nutrition, health & aging.
[269] W. Markesbery,et al. Recent Clinical-Pathologic Research on the Causes of Dementia in Late Life: Update From the Honolulu-Asia Aging Study , 2005, Journal of geriatric psychiatry and neurology.
[270] Ralph B. D’Agostino,et al. Obesity, diabetes and cognitive deficit: The Framingham Heart Study , 2005, Neurobiology of Aging.
[271] D. Leys,et al. Stroke Syndromes: Poststroke dementia , 2001 .
[272] Jianchun Yu,et al. Acupuncture improved cognitive impairment caused by multi-infarct dementia in rats , 2005, Physiology & Behavior.
[273] François Béland,et al. Trajectories of cognitive decline and social relations. , 2005, The journals of gerontology. Series B, Psychological sciences and social sciences.
[274] R. Mayeux,et al. Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. , 2005, Archives of neurology.
[275] S. Salloway,et al. Donepezil in Vascular Dementia: Combined Analysis of Two Large-Scale Clinical Trials , 2005, Dementia and Geriatric Cognitive Disorders.
[276] H. Dodge,et al. Alcohol consumption and cognitive function in late life , 2005, Neurology.
[277] S. Zeger,et al. Is there cognitive decline 1 year after CABG? , 2005, Neurology.
[278] R. Collins,et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.
[279] Hilkka Soininen,et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. , 2005, Archives of neurology.
[280] Anne-Sophie Rigaud,et al. Relationship Between Arterial Stiffness and Cognitive Function in Elderly Subjects With Complaints of Memory Loss , 2005, Stroke.
[281] Sudha Seshadri,et al. Homocysteine and cognitive performance in the Framingham offspring study: age is important. , 2005, American journal of epidemiology.
[282] Richard H. Swartz,et al. A New Visual Rating Scale to Assess Strategic White Matter Hyperintensities Within Cholinergic Pathways in Dementia , 2005, Stroke.
[283] M. Woodward,et al. Effects of Blood Pressure Lowering on Cerebral White Matter Hyperintensities in Patients With Stroke: The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy , 2005, Circulation.
[284] Edward G Lakatta,et al. Arterial aging: is it an immutable cardiovascular risk factor? , 2005, Hypertension.
[285] N. Schuff,et al. Longitudinal volumetric MRI change and rate of cognitive decline , 2005, Neurology.
[286] W. Arts,et al. Novel mutations in three families confirm a major role of COL4A1 in hereditary porencephaly , 2005, Journal of Medical Genetics.
[287] L H Kuller,et al. Neuropsychological characteristics of mild cognitive impairment subgroups , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[288] Don L. Armstrong,et al. Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease , 2005, Nature Medicine.
[289] R. Nandhagopal,et al. Thalamic disequilibrium syndrome after thrombolytic therapy for acute myocardial infarction , 2005, Neurology.
[290] B. Winblad,et al. The age-dependent relation of blood pressure to cognitive function and dementia , 2005, The Lancet Neurology.
[291] Constantine Lyketsos,et al. Dementia and Alzheimer's Disease Incidence in Relationship to Cardiovascular Disease in the Cardiovascular Health Study Cohort , 2005, Journal of the American Geriatrics Society.
[292] Michael F O'Rourke,et al. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. , 2005, Hypertension.
[293] L. Ferrucci,et al. Vitamin E levels, cognitive impairment and dementia in older persons: the InCHIANTI study , 2005, Neurobiology of Aging.
[294] Stéphane Laurent,et al. Structural and Genetic Bases of Arterial Stiffness , 2005, Hypertension.
[295] M. M. Mielke,et al. High total cholesterol levels in late life associated with a reduced risk of dementia , 2005, Neurology.
[296] C. Lyketsos,et al. Classification of vascular dementia in the Cardiovascular Health Study Cognition Study , 2005, Neurology.
[297] W. Jagust,et al. Determinants of vascular dementia in the Cardiovascular Health Cognition Study , 2005, Neurology.
[298] J. Morris,et al. Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study. , 2005, Archives of neurology.
[299] D. Kass,et al. Mechanisms, pathophysiology, and therapy of arterial stiffness. , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[300] M. Fioravanti,et al. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. , 2005, The Cochrane database of systematic reviews.
[301] L. Kuller,et al. Coronary Artery Calcium: Associations with Brain Magnetic Resonance Imaging Abnormalities and Cognitive Status , 2005, Journal of the American Geriatrics Society.
[302] J. Cummings,et al. The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.
[303] Michael F O'Rourke,et al. Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertension. , 2005, Hypertension.
[304] P. Gorelick. William M. Feinberg Lecture: Cognitive Vitality and the Role of Stroke and Cardiovascular Disease Risk Factors , 2005, Stroke.
[305] D. Harvey,et al. Measures of brain morphology and infarction in the framingham heart study: establishing what is normal , 2005, Neurobiology of Aging.
[306] V. Feigin,et al. Does blood pressure lowering treatment prevents dementia or cognitive decline in patients with cardiovascular and cerebrovascular disease? , 2005, Journal of the Neurological Sciences.
[307] J. Schneider,et al. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions , 2005, Neurology.
[308] S. Love,et al. Aβ-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy , 2005 .
[309] L. Launer. The epidemiologic study of dementia: a life-long quest? , 2005, Neurobiology of Aging.
[310] R. Mayeux,et al. Atherosclerosis and AD , 2005, Neurology.
[311] R. Brookmeyer,et al. Calcium channel blockers and risk of AD: the Baltimore Longitudinal Study of Aging , 2005, Neurobiology of Aging.
[312] P Dastidar,et al. Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population‐based study , 2005, Scandinavian journal of rheumatology.
[313] W. Markesbery,et al. AD lesions and infarcts in demented and non‐demented Japanese‐American men , 2005, Annals of neurology.
[314] Norman J Beauchamp,et al. Incidence, Manifestations, and Predictors of Worsening White Matter on Serial Cranial Magnetic Resonance Imaging in the Elderly: The Cardiovascular Health Study , 2005, Stroke.
[315] Uo Geriatria,et al. Arterial stiffness is an independent risk factor for cognitive impairment in the elderly: A pilot study , 2005 .
[316] M. Woodward,et al. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke. The PROGRESS MRI Substudy , 2005 .
[317] F. Sherriff,et al. Memantine for dementia. , 2005, The Cochrane database of systematic reviews.
[318] K. Yaffe,et al. Chronic kidney disease and cognitive impairment in menopausal women. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[319] R. Stewart,et al. A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. , 2005, Archives of neurology.
[320] J. LaManna,et al. The neurovascular unit and its growth factors: coordinated response in the vascular and nervous systems , 2004, Neurological research.
[321] P. Deyn,et al. Neurological complications in renal failure: a review , 2004, Clinical Neurology and Neurosurgery.
[322] E. Reiman,et al. Vascular risk factors, incidence of MCI, and rates of progression to dementia , 2004, Neurology.
[323] Paul G. Ince,et al. Vascular pathologies and cognition in a population-based cohort of elderly people , 2004, Journal of the Neurological Sciences.
[324] S. Gauthier,et al. Treatment of vascular dementia—evidence from clinical trials with cholinesterase inhibitors , 2004, Journal of the Neurological Sciences.
[325] C. Ballard,et al. Towards defining the neuropathological substrates of vascular dementia , 2004, Journal of the Neurological Sciences.
[326] C. Iadecola,et al. Angiotensin II Impairs Neurovascular Coupling in Neocortex Through NADPH Oxidase–Derived Radicals , 2004, Circulation research.
[327] S. Greenberg,et al. White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage , 2004, Neurology.
[328] M. Ihara,et al. White Matter Lesions and Glial Activation in a Novel Mouse Model of Chronic Cerebral Hypoperfusion , 2004, Stroke.
[329] P. Gorelick,et al. Risk Factors for Vascular Dementia and Alzheimer Disease , 2004, Stroke.
[330] J. Manson,et al. Physical activity, including walking, and cognitive function in older women. , 2004, JAMA.
[331] R. Petersen. Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.
[332] A. Hofman,et al. The Study on COgnition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization , 2004, Journal of hypertension.
[333] Rhoda Au,et al. Cerebral Microbleeds: Prevalence and Associations With Cardiovascular Risk Factors in the Framingham Study , 2004, Stroke.
[334] Charles DeCarli,et al. Stroke Risk Profile Predicts White Matter Hyperintensity Volume: The Framingham Study , 2004, Stroke.
[335] 曲东锋. Stroke Prevention by Aggressive Reduction in Cholesterol Levels , 2004 .
[336] L. Kuller,et al. Moderate renal impairment and risk of dementia among older adults: the Cardiovascular Health Cognition Study. , 2004, Journal of the American Society of Nephrology : JASN.
[337] Eric E. Smith,et al. Hemorrhage Burden Predicts Recurrent Intracerebral Hemorrhage After Lobar Hemorrhage , 2004, Stroke.
[338] Sudha Seshadri,et al. Dementia After Stroke: The Framingham Study , 2004, Stroke.
[339] A. Hofman,et al. Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. , 2004, Archives of neurology.
[340] C. Iadecola. Neurovascular regulation in the normal brain and in Alzheimer's disease , 2004, Nature Reviews Neuroscience.
[341] Richard Mayeux,et al. Relation of plasma lipids to Alzheimer disease and vascular dementia. , 2004, Archives of neurology.
[342] H. Budka,et al. Topographical and cytopathological lesion analysis of the white matter in Binswanger’s disease brains , 2004, Acta Neuropathologica.
[343] J. Schneider,et al. Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology , 2004, Neurology.
[344] Eric J Topol,et al. Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins , 2004, The Lancet.
[345] H. Feldman,et al. Emerging Therapies for Vascular Dementia and Vascular Cognitive Impairment , 2004, Stroke.
[346] M. Caldwell,et al. American Heart Association: Council on Cardiovascular Nursing , 2004, The Journal of cardiovascular nursing.
[347] Lewis H Kuller,et al. Incidence and Prevalence of Dementia in the Cardiovascular Health Study , 2004, Journal of the American Geriatrics Society.
[348] M. Frosch,et al. Clinical manifestations of cerebral amyloid angiopathy–related inflammation , 2004, Annals of neurology.
[349] D Kromhout,et al. Dietary intake of fatty acids and fish in relation to cognitive performance at middle age , 2004, Neurology.
[350] J. Birks,et al. Donepezil for vascular cognitive impairment. , 2004, The Cochrane database of systematic reviews.
[351] M Orrell,et al. Cognitive rehabilitation and cognitive training for early-stage Alzheimer's disease and vascular dementia. , 2003, The Cochrane database of systematic reviews.
[352] S. Salloway,et al. Efficacy and Tolerability of Donepezil in Vascular Dementia: Positive Results of a 24-Week, Multicenter, International, Randomized, Placebo-Controlled Clinical Trial , 2003, Stroke.
[353] John Breitner,et al. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. , 2003, Archives of neurology.
[354] W. Jagust,et al. Homocysteine and cognitive function in the Sacramento Area Latino Study on Aging. , 2003, The American journal of clinical nutrition.
[355] R. Doody,et al. Donepezil in vascular dementia , 2003, Neurology.
[356] B. Trimarco,et al. Left Ventricular Hypertrophy Is Associated With Asymptomatic Cerebral Damage in Hypertensive Patients , 2003, Stroke.
[357] G. Mcclearn,et al. Does aspirin protect against Alzheimer's dementia? A study in a Swedish population-based sample aged ≥80 years , 2003, European Journal of Clinical Pharmacology.
[358] S. Yeh,et al. Influence of social support on cognitive function in the elderly , 2003, BMC health services research.
[359] Neil Chapman,et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. , 2003, Archives of internal medicine.
[360] A. Hofman,et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial , 2003, Journal of hypertension.
[361] S. Riedel-Heller,et al. Mild cognitive impairment: prevalence and incidence according to different diagnostic criteria , 2003, British Journal of Psychiatry.
[362] T. Strandberg. Alzheimer's disease and angiogenesis , 2003, The Lancet.
[363] J. Schneider,et al. Relation of cerebral infarctions to dementia and cognitive function in older persons , 2003, Neurology.
[364] D. Leys,et al. Poststroke dementia: influence of hippocampal atrophy. , 2003, Archives of neurology.
[365] B. Heude,et al. Cognitive decline and fatty acid composition of erythrocyte membranes--The EVA Study. , 2003, The American journal of clinical nutrition.
[366] A. Hofman,et al. Silent brain infarcts and the risk of dementia and cognitive decline. , 2003, The New England journal of medicine.
[367] P. Sandercock,et al. Is Breakdown of the Blood-Brain Barrier Responsible for Lacunar Stroke, Leukoaraiosis, and Dementia? , 2003, Stroke.
[368] A. Vagnucci,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Alzheimer's Disease and Angiogenesis , 2022 .
[369] B. Winblad,et al. Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study. , 2003, Archives of neurology.
[370] Matthijs Oudkerk,et al. Incidence and Risk Factors of Silent Brain Infarcts in the Population-Based Rotterdam Scan Study , 2003, Stroke.
[371] C. Iadecola,et al. Converging Pathogenic Mechanisms in Vascular and Neurodegenerative Dementia , 2003, Stroke.
[372] P. Whitehouse,et al. Vinpocetine for cognitive impairment and dementia. , 2003, The Cochrane database of systematic reviews.
[373] J. Stam,et al. Retinal arterial changes correlate with cerebral small-vessel disease , 2002, Neurology.
[374] J. Jolles,et al. Cigarette smoking and alcohol consumption in relation to cognitive performance in middle age. , 2002, American journal of epidemiology.
[375] Rita Moretti,et al. Rivastigmine in subcortical vascular dementia An open 22-month study , 2002, Journal of the Neurological Sciences.
[376] A Hofman,et al. Homocysteine and cognitive function in the elderly , 2002, Neurology.
[377] J. O'Brien,et al. Cognitive Associations of Subcortical White Matter Lesions in Older People , 2002, Annals of the New York Academy of Sciences.
[378] G. Wilcock,et al. A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500) , 2002, International clinical psychopharmacology.
[379] Jan A Staessen,et al. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. , 2002, Archives of internal medicine.
[380] Curt D. Furberg,et al. Incidence, Manifestations, and Predictors of Brain Infarcts Defined by Serial Cranial Magnetic Resonance Imaging in the Elderly: The Cardiovascular Health Study , 2002, Stroke.
[381] R. Hébert,et al. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. , 2002, American journal of epidemiology.
[382] R. Schmidt,et al. Early inflammation and dementia: A 25‐year follow‐up of the Honolulu‐Asia aging study , 2002, Annals of neurology.
[383] R. Collins,et al. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial , 2002 .
[384] Tw. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial , 2002, The Lancet.
[385] C. Iadecola,et al. Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein. , 2002, American journal of physiology. Heart and circulatory physiology.
[386] J. Orgogozo,et al. Efficacy and Safety of Memantine in Patients With Mild to Moderate Vascular Dementia: A Randomized, Placebo-Controlled Trial (MMM 300) , 2002, Stroke.
[387] Steven A. Goldman,et al. Coordinated Interaction of Neurogenesis and Angiogenesis in the Adult Songbird Brain , 2002, Neuron.
[388] L. Launer,et al. Cerebral amyloid angiopathy and cognitive function: The HAAS autopsy study , 2002, Neurology.
[389] C. Cotman,et al. Exercise: a behavioral intervention to enhance brain health and plasticity , 2002, Trends in Neurosciences.
[390] K. Jellinger,et al. Alzheimer disease and cerebrovascular pathology: an update , 2002, Journal of Neural Transmission.
[391] John R. M. Copeland,et al. Principles and practice of geriatric psychiatry , 2002 .
[392] Serge Gauthier,et al. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial , 2002, The Lancet.
[393] L. Launer,et al. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. , 2002, Diabetes.
[394] E Rostrup,et al. Cerebral Perfusion and Cerebrovascular Reactivity Are Reduced in White Matter Hyperintensities , 2002, Stroke.
[395] Chao Zhao,et al. The Age-Related Decrease in CNS Remyelination Efficiency Is Attributable to an Impairment of Both Oligodendrocyte Progenitor Recruitment and Differentiation , 2002, The Journal of Neuroscience.
[396] Berrit C Stroehla,et al. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. , 2002, American journal of epidemiology.
[397] S. Wisniewski,et al. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment , 2002, Annals of neurology.
[398] A. Coats. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial , 2002 .
[399] S. A. Areosa,et al. Effect of the treatment of Type II diabetes mellitus on the development of cognitive impairment and dementia. , 2002, The Cochrane database of systematic reviews.
[400] W. Jagust. Untangling vascular dementia , 2001, The Lancet.
[401] H. Chabriat,et al. Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis , 2001, The Lancet.
[402] D. Cornfield,et al. Aβ-peptides enhance vasoconstriction in cerebral circulation , 2001 .
[403] Gitte M. Knudsen,et al. Cerebral Blood Flow in Patients With Chronic Heart Failure Before and After Heart Transplantation , 2001, Stroke.
[404] R. Mayeux,et al. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. , 2001, American journal of epidemiology.
[405] D. Bennett,et al. Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. , 2001, Archives of neurology.
[406] M. Woodward,et al. Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack , 2001 .
[407] V Hachinski,et al. Progression of impairment in patients with vascular cognitive impairment without dementia , 2001, Neurology.
[408] P. Luiten,et al. Cerebral microvascular pathology in aging and Alzheimer's disease , 2001, Progress in Neurobiology.
[409] Monique M. B. Breteler,et al. Incidence of dementia: does gender make a difference? , 2001, Neurobiology of Aging.
[410] C. Maffeis,et al. Long-Term Effects of Childhood Obesity on Morbidity and Mortality , 2001, Hormone Research in Paediatrics.
[411] H. Soininen,et al. Midlife vascular risk factors and late-life mild cognitive impairment , 2001, Neurology.
[412] T. Grabowski,et al. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy , 2001, Annals of neurology.
[413] A. Hofman,et al. Antihypertensive drugs and incidence of dementia: the Rotterdam Study , 2001, Neurobiology of Aging.
[414] R. Royall,et al. Cognitive changes 5 years after coronary artery bypass grafting: is there evidence of late decline? , 2001, Archives of neurology.
[415] G. Mead,et al. Association between cognitive impairment and atrial fibrillation: a systematic review. , 2001, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[416] S. Greenberg,et al. Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston Criteria , 2003, Current atherosclerosis reports.
[417] Ian G. McKeith,et al. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales , 2001, The Lancet.
[418] A. Folsom,et al. Cardiovascular risk factors and cognitive decline in middle-aged adults , 2001, Neurology.
[419] C. Patterson,et al. The Recognition, Assessment and Management of Dementing Disorders: Conclusions from the Canadian Consensus Conference on Dementia , 1999, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[420] J. Salonen,et al. Atherosclerosis and cognitive functioning , 2001 .
[421] M. Bayes,et al. The Probability of , 2001 .
[422] L. Flicker,et al. Piracetam for dementia or cognitive impairment. , 2001, The Cochrane database of systematic reviews.
[423] L. Ferrucci,et al. Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial. , 2001, American journal of epidemiology.
[424] D. Cornfield,et al. A beta-peptides enhance vasoconstriction in cerebral circulation. , 2001, American journal of physiology. Heart and circulatory physiology.
[425] George A. Carlson,et al. Exogenous Aβ1–40 Reproduces Cerebrovascular Alterations Resulting from Amyloid Precursor Protein Overexpression in Mice , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[426] M. Kaste,et al. Comparison of Different Clinical Criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the Diagnosis of Vascular Dementia , 2000, Stroke.
[427] W. Kukull,et al. Epidemiology of dementia: concepts and overview. , 2000, Neurologic clinics.
[428] W. Jagust,et al. Neuropathologic Substrates of Ischemic Vascular Dementia , 2000, Journal of neuropathology and experimental neurology.
[429] C M Burchfiel,et al. Metabolic Cardiovascular Syndrome and Risk of Dementia in Japanese-American Elderly Men: The Honolulu-Asia Aging Study , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[430] I. McKeith,et al. Anxiety, depression and psychosis in vascular dementia: prevalence and associations. , 2000, Journal of affective disorders.
[431] R. Corbeil,et al. Coping With Dementia: Evaluation of Four Nonpharmacologic Interventions , 2000, International Psychogeriatrics.
[432] Faith M. Gunning-Dixon,et al. The cognitive correlates of white matter abnormalities in normal aging: a quantitative review. , 2000, Neuropsychology.
[433] J. Parisi,et al. De novo mutation in the Notch3 gene causing CADASIL , 2000, Annals of neurology.
[434] R. Havlik,et al. Midlife blood pressure and dementia: the Honolulu–Asia aging study☆ , 2000, Neurobiology of Aging.
[435] A. King,et al. The question of familial meningiomas and schwannomas: , 2000, Neurology.
[436] G C Roman,et al. Research criteria for subcortical vascular dementia in clinical trials. , 2000, Journal of neural transmission. Supplementum.
[437] A. Hofman,et al. Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. , 2000, Neurology.
[438] A. Hofman,et al. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. , 2000, Neurology.
[439] A Hofman,et al. Diabetes mellitus and the risk of dementia , 1999, Neurology.
[440] A Hofman,et al. Gender differences in the incidence of AD and vascular dementia , 1999, Neurology.
[441] C. DeCarli,et al. Imaging of static brain lesions in vascular dementia: implications for clinical trials. , 1999, Alzheimer disease and associated disorders.
[442] M. Kaste,et al. Clinical and radiological determinants of prestroke cognitive decline in a stroke cohort , 1999, Journal of neurology, neurosurgery, and psychiatry.
[443] R. D'Agostino,et al. Alcohol consumption and cognitive performance in the Framingham Heart Study. , 1999, American journal of epidemiology.
[444] Zsuzsanna Nagy,et al. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease , 1999, The Lancet.
[445] B. Winblad,et al. Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use. , 1999, Archives of neurology.
[446] W. Jagust,et al. The Role of APOE ∊4 in Modulating Effects of Other Risk Factors for Cognitive Decline in Elderly Persons , 1999 .
[447] F. Fazekas,et al. MRI white matter hyperintensities , 1999, Neurology.
[448] A. Straube,et al. Muscle and skin biopsies are a sensitive diagnostic tool in the diagnosis of CADASIL , 1999, Journal of Neurology.
[449] K Yaffe,et al. Depressive symptoms and cognitive decline in nondemented elderly women: a prospective study. , 1999, Archives of general psychiatry.
[450] C. Jack,et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.
[451] P Kapeller,et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. , 1999, AJNR. American journal of neuroradiology.
[452] E. Tangalos,et al. Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .
[453] D. Borchelt,et al. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein , 1999, Nature Neuroscience.
[454] T. Manolio,et al. Relationships of cerebral MRI findings to ultrasonographic carotid atherosclerosis in older adults : the Cardiovascular Health Study. CHS Collaborative Research Group. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[455] C. Patterson,et al. The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[456] C. Benesch,et al. Small Chronic Hemorrhages and Ischemic Lesions in Association With Spontaneous Intracerebral Hematomas , 1999 .
[457] W. Jagust,et al. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. , 1999, JAMA.
[458] J. Tuomilehto,et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial , 1998, The Lancet.
[459] T. Manolio,et al. Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. , 1998, Archives of neurology.
[460] J. Loscalzo,et al. Homocysteine and atherothrombosis. , 1998, The New England journal of medicine.
[461] R. Roos,et al. Microvasculopathy is associated with the number of cerebrovascular lesions in hereditary cerebral hemorrhage with amyloidosis, Dutch type. , 1998, Stroke.
[462] A. Hofman,et al. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study , 1998, The Lancet.
[463] M. Esiri,et al. Neuropathological assessment of the lesions of significance in vascular dementia , 1997, Journal of neurology, neurosurgery, and psychiatry.
[464] J. Weissenbach,et al. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients , 1997, The Lancet.
[465] E. Shimosegawa,et al. Subcortical hypoperfusion associated with asymptomatic white matter lesions on magnetic resonance imaging. , 1997, Stroke.
[466] Jan A Staessen,et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension , 1997, The Lancet.
[467] E. Schiffrin,et al. How to assess vascular remodelling in small and medium‐sized muscular arteries in humans , 1997, Journal of hypertension.
[468] W. Markesbery,et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.
[469] S. M. Sumi,et al. Clinical-neuropathologic findings in multi-infarct dementia , 1997, Neurology.
[470] A Hofman,et al. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. , 1997, Stroke.
[471] E. Feskens,et al. Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. , 1997, American journal of epidemiology.
[472] D J Foley,et al. Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study. , 1996, JAMA.
[473] L. Fried,et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. , 1996, Stroke.
[474] A. Hofman,et al. Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study. , 1996, American journal of epidemiology.
[475] W. O'Fallon,et al. Dementia after ischemic stroke , 1996, Neurology.
[476] M. Mullan,et al. beta-Amyloid-mediated vasoactivity and vascular endothelial damage. , 1996, Nature.
[477] J. Haxby,et al. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults , 1995, Neurology.
[478] B. Dubois,et al. Clinical spectrum of CADASIL: a study of 7 families , 1995, The Lancet.
[479] L. Thal,et al. Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. , 1995, Archives of neurology.
[480] Diederick E Grobbee,et al. Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study , 1995, BMJ.
[481] R. Zulli,et al. Media: lumen ratio in human small resistance arteries is related to forearm minimal vascular resistance , 1995, Journal of hypertension.
[482] C. Bell. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders , 1994 .
[483] O L Lopez,et al. Reliability of NINDS‐AIREN clinical criteria for the diagnosis of vascular dementia , 1994, Neurology.
[484] A. Hofman,et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population‐based study , 1994, Neurology.
[485] Albert Hofman,et al. Cognitive Correlates of Ventricular Enlargement and Cerebral White Matter Lesions on Magnetic Resonance Imaging: The Rotterdam Study , 1994, Stroke.
[486] D L Patrick,et al. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). , 1994, American journal of preventive medicine.
[487] M. Alderman,et al. Role of Preclinical Cardiovascular Disease in the Evolution From Risk Factor Exposure to Development of Morbid Events , 1993, Circulation.
[488] Gerardo Heiss,et al. Carotid Artery Intimal‐Medial Thickness Distribution in General Populations As Evaluated by B‐Mode Ultrasound , 1993, Stroke.
[489] A Hofman,et al. Cerebral white matter lesions and atherosclerosis in the Rotterdam Study , 1993, The Lancet.
[490] J. Fisk,et al. COGNITIVE IMPAIRMENT AND AUTOANTLBODIES IN SYSTEMIC LUPUS ERYTHEMATOSUS , 1993 .
[491] R B D'Agostino,et al. Incidence of dementia and probable Alzheimer's disease in a general population , 1993, Neurology.
[492] J. Fisk,et al. Cognitive impairment and autoantibodies in systemic lupus erythematosus. , 1993, British journal of rheumatology.
[493] V. Hachinski. Preventable senility: a call for action against the vascular dementias , 1992, The Lancet.
[494] T. Keller,et al. Loss of cerebral regulation during cardiac output variations in focal cerebral ischemia. , 1992, Journal of neurosurgery.
[495] R. Mayeux,et al. Dementia after stroke , 1992, Neurology.
[496] W. Jagust,et al. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers , 1992, Neurology.
[497] A. Hofman,et al. The prevalence of vascular dementia in europe: Facts and fragments from 1980–1990 studies , 1991, Annals of neurology.
[498] J. Vonsattel,et al. Cerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study , 1991, Annals of neurology.
[499] R B D'Agostino,et al. Probability of stroke: a risk profile from the Framingham Study. , 1991, Stroke.
[500] 古田 晶子. Medullary arteries in aging and dementia , 1991 .
[501] J. Hardy,et al. Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). , 1990, Science.
[502] H. Chui,et al. Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review , 1990, Brain Research Bulletin.
[503] R. Collins,et al. Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.
[504] Leukoaraiosis and dementia: To the editor , 1990 .
[505] A. Heagerty,et al. Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation--contraction coupling in isolated resistance vessels from essential hypertensives. , 1987, Circulation research.
[506] P Pignoli,et al. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. , 1986, Circulation.
[507] A. Brun,et al. A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study , 1986, Annals of neurology.
[508] T. Mandybur. Cerebral Amyloid Angiopathy: The Vascular Pathology and Complications , 1986, Journal of neuropathology and experimental neurology.
[509] A. Damasio,et al. The anatomic basis of pure alexia , 1983, Neurology.
[510] H. Vinters,et al. Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. , 1983, Stroke.
[511] D. Benson,et al. Angular gyrus syndrome simulating Alzheimer's disease. , 1982, Archives of neurology.
[512] N. Lassen,et al. Multi-infarct dementia. A cause of mental deterioration in the elderly. , 1974, Lancet.
[513] P M Moodie,et al. COHORT , 1971, The Medical journal of Australia.
[514] Alistair Burns,et al. Observations on the brains of demented old people. B.E. Tomlinson, G. Blessed and M. Roth, Journal of the Neurological Sciences (1970) 11, 205–242; (1968) 7, 331–356 , 1997 .
[515] M. Roth,et al. Observations on the brains of non-demented old people. , 1968, Journal of the neurological sciences.
[516] M. Roth. The natural history of mental disorder in old age. , 1955, The Journal of mental science.
[517] 박귀태,et al. A Type 2 Diabetes–Associated Functional Regulatory Variant in a Pancreatic Islet Enhancer at the ADCY5 Locus , 2017, Diabetes.